Skip to main content

Table 1 Definition of the cancer groups by ICD-O site and histology codes

From: Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site

Cancer

Site

Morphology

Behavior

Lip

0-9

8000-9589

2-9

Tongue

19-29

8000-9589

2-9

Salivary

79-89

8000-9589

2-9

Pharynx

90-119, 129-39,

140-48

8000-9589

2-9

Esophagus

150-159

8000-9589

2-9

Stomach

160-169

8000-9589

2-9

Small intestine

170-179

8000-9589

2-9

Colon

180, 182-189, 260

8000-8239, 8250-8719

2-9

Rectum

199, 209

8000-8239, 8250-8719

2-9

Anus

210-218

8000-9589

2-9

Liver/hepatic

220, 221

8000-9589

2-9

Gallbladder

239

8000-9589

2-9

Pancreasα

250-259

8000-1, 8010, 8140-1, 8480-1, 8500

2-9

Larynx

320-329

8000-9589

2-9

Lung/bronchus

340-349

8000-9589

2-9

Bone

400-419

8000-9589

2-9

Melanoma

0-809

8720-8790

2-9

Breast

500-509

8000-9589

2-9

Cervix

530-539

8000-9589

2-9

Endometrial†

540-549, 559

8010, 8050, 8140, 8210, 8260, 8310, 8323, 8380, 8382, 8441, 8460-1,

8480-81, 8560, 8570

2-9

Ovary

569

8000-9589

2-9

Female Genital (vulva, vagina and other unspecified)

510-519, 529, 570-79

8000-9589

2-9

Prostate

619

8000-9589

2-9

Testis

620-629

8000-9589

2-9

Bladder

670-679

8000-9589

2-9

Kidney

649, 659

8000-9589

2-9

Brain

710-719

8000-9529, 9540-9589

2-9

Thyroid

739

8000-9589

2-9

Multiple myeloma

0-809

9732

2-9

Chronic lymphocytic leukemia

0-809

8823

2-9

Acute lymphocytic leukemia

0-809

9821,9828,9831-7

2-9

Chronic myelocytic leukemia

0-809

9863, 9875, 9876

2-9

Acute myelocytic leukemia

0-809

9840,9861,9866-67, 9871-4, 9891, 9895-7, 9920

2-9

Non-Hodgkin's lymphoma

0-809

9530, 9590-1, 9596, 9598, 9670-1, 9673, 9675, 9678-80, 9684, 9687,

9689-91, 9695, 9698-702, 9705,

9708-9, 9714, 9716-9, 9727-29,

9755, 9764, 9827

2-9

Hodgkin's lymphoma

0-809

9650-5, 9659, 9661-7, 9945, 9946, 9948

2-9

Oropharynx

19, 24,51-52,

90-91,99,100-104,

108-9

8000-9589

2-9

  1. α Pancreatic adenocarcinoma only
  2. † Excluding endometrial sarcomas